Articles by Eric Langer - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Eric Langer

Alternative Expression Systems May Cut Bioprocessing Costs, Open New CMO Opportunities

What manufacturing options will be available for novel expression systems?
Feb 28, 2014

Novel expression systems such as plant-based manufacturing platforms are expected to dramatically lower manufacturing costs. How will the market respond with outsourcing options?

Novel Expression Systems Opening CMO Opportunities

CMOs may find opportunities in alternative expression services.
Feb 2, 2014

CMOs may find opportunities in alternative expression services.

Disposable Applications in Demand for BioPharma

Interest in chromatography innovation continues to decline.
Dec 4, 2013

Interest in chromatography innovation continues to decline.

Disposable Applications in Demand by Biopharma

Interest in chromatography innovation continues to decline.
Nov 2, 2013

Data from BioPlan Associates’ 10th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production suggest that the interest in disposable devices has begun to extend to biopharma operations beyond basic single-use bags and connectors.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
25%
Attracting a skilled workforce
31%
Obtaining/maintaining adequate financing
13%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
FindPharma Custom Search
Click here